Logos Global Management »

Vera Therapeutics shares owned by Logos Global Management

Quarter-by-quarter ownership of Vera Therapeutics (VERA) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Vera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vera Therapeutics held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vera Therapeutics by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $34M 950k 36.18
2024-03-31 $25M 575k 43.12
2022-12-31 $5.5M 285k 19.35
2022-03-31 $9.0M 385k 23.49
2021-12-31 $1.3M 50k 26.72

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Vera Therapeutics

T. Rowe Price Associates
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Commodore Capital
State Street Corporation
Holocene Advisors
Kynam Capital Management
Samlyn Capital
Paradigm Biocapital Advisors
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Logos Global Management

View all funds holding Vera Therapeutics